Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-21-046679

Options or other derivatives

  • Director acquired 18,351 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nicholson, C. David · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +18,351 18,351 D
Loading xslF345X03/ownership.xml…